Dexamethasone 20mg

DRUG3 trials

Sponsors

Kosin University Gospel Hospital, Epizyme, Inc., Salem Anaesthesia Pain Clinic

Conditions

Refractory Hematologic MalignancyRelapsed Hematologic MalignancyRelapsed and/or refractorY Multiple MyelomaSickle Cell AbnormalitySickle Cell Disease

Phase 1

A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.

WithdrawnNCT05205252

Epizyme, Inc.Refractory Hematologic Malignancy, Relapsed Hematologic Malignancy

Start: 2021-12-22End: 2023-07-05Updated: 2023-08-15

Phase 2

The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)

CompletedNCT03242460

Kosin University Gospel HospitalRelapsed and/or refractorY Multiple Myeloma

Start: 2015-05-12End: 2019-05-02Updated: 2020-02-20

Unknown Phase

Steroid Injection for Sickle Cell Arthropathy Pain Therapy

CompletedNCT05983055

Salem Anaesthesia Pain ClinicSickle Cell Abnormality, Sickle Cell Disease

Start: 2018-01-30End: 2024-03-31Updated: 2025-01-27

Related Papers

P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES

HemaSphere2022-06-01